News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Onconova Therapeutics Inc. Appoints Dr. Thomas J. McKearn as President, Research and Development



10/9/2012 10:35:24 AM

NEWTOWN, Pa. & PENNINGTON, N.J.--(BUSINESS WIRE)--Onconova Therapeutics, Inc. today announced the appointment of Thomas J. McKearn, M.D., Ph.D. as President, Research and Development. Dr. McKearn is a veteran drug development executive who most recently served as Vice President, Strategic Clinical Affairs at Agennix, Inc. “Thomas brings substantial leadership experience in all key aspects of drug development to Onconova, including research, clinical development, business operations, and corporate development,” said Ramesh Kumar, Chief Executive Officer of Onconova. “I am very pleased to welcome him to our executive team and look forward to his contributions as the Phase III trial of rigosertib in Myelodysplastic Syndromes progresses toward pivotal data in 2013.”

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES